Orchard Therapeutics plc

ORTX · NASDAQ
Analyze with AI
$16.70+$0.05 (+0.3%)
At close:Jan 23, 2024, 9:00 PM UTC
P/E TTM-27.11
P/B TTM2.17
P/S TTM54.41
Dividend Yield0%
EPS-$4.10
Beta0.553
Valuation
PEG Ratio-0.27
FCF Yield-21.70%
EV / EBITDA-45.77
More On Valuation »
Quality
ROIC-15.86%
Gross Margin65.17%
Cash Conv. Ratio1.28
More On Quality »
Growth
Revenue 3Y CAGR39.11%
FCF Growth35.71%
More On Growth »
Safety
Net Debt / EBITDA1.28
Interest Coverage-33.86
More On Safety »
Efficiency
Inventory Turnover0.72
Cash Conv. Cycle-134.99
More On Efficiency »

Orchard Therapeutics plc (ORTX) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Orchard Therapeutics plc (ORTX) stock price today?

As of Jan 23, 2024, 9:00 PM UTC, Orchard Therapeutics plc (ORTX) stock is trading at $16.70. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ORTX stock quotes for informed trading decisions.

What is Orchard Therapeutics plc's market capitalization?

Orchard Therapeutics plc (ORTX) has a market capitalization of approximately $380.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Orchard Therapeutics plc's size relative to other companies in the USD market. The market cap figure updates automatically as the ORTX stock price changes.

What is the 52-week range for Orchard Therapeutics plc stock?

Orchard Therapeutics plc (ORTX) stock has traded in a 52-week range of $4.24 — $16.72. The 52-week range shows the highest and lowest prices at which ORTX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Orchard Therapeutics plc stock price to this range provides context for recent price action.

How much trading volume does Orchard Therapeutics plc stock have?

Orchard Therapeutics plc (ORTX) stock recently traded approximately 372.3K shares. Trading volume indicates market liquidity and investor interest in ORTX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Orchard Therapeutics plc stock.

Does Orchard Therapeutics plc pay dividends to shareholders?

Yes, Orchard Therapeutics plc (ORTX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Orchard Therapeutics plc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Orchard Therapeutics plc's intraday price range?

Today, Orchard Therapeutics plc (ORTX) stock has traded in a range of $16.64 — $16.72. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ORTX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Orchard Therapeutics plc stock data?

AlphaPilot sources real-time ORTX stock quotes, fundamental financial data, and historical price charts for Orchard Therapeutics plc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Orchard Therapeutics plc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ORTX stock performance.